GoHealth, Inc. GOCOQ
0.34
0.00
0.00%
as of 28 Jul
- Market cap
- $8.5M
- P/E
- 0.0×
Follow GOCOQ
| Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
— | 1,946.00 | 1,946.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
— | 0.00 | 0.00 | 1.31 | 0.38 | 0.14 | 0.17 | 0.17 | 0.08 |
P/FCF ratio |
— | 0.00 | 0.00 | 0.00 | 0.00 | 1.81 | 1.27 | 0.00 | 0.00 |
P/Operating CF |
— | (68.29) | (68.29) | (8.04) | (1.77) | (2.09) | 1.71 | 9.15 | (0.71) |
P/B ratio |
— | 4.59 | 4.59 | 0.82 | 0.45 | 0.16 | 0.30 | 0.33 | 0.00 |
Price to Tangible BV |
— | 4.59 | 4.59 | 3.55 | 1.35 | 2.05 | 13.37 | 1.30 | 0.00 |
EV/Sales |
— | 0.00 | 0.00 | 1.81 | 1.19 | 1.32 | 1.00 | 0.95 | 2.29 |
EV/EBITDA |
— | 0.00 | 0.00 | 43.63 | 184.66 | 0.00 | 26.84 | 7.03 | 0.00 |
EV/Operating CF |
— | (738.43) | (738.43) | (13.92) | (4.22) | 13.67 | 6.70 | (35.07) | (6.79) |
EV/FCF |
— | (87.48) | (87.48) | (12.35) | (3.96) | 17.56 | 7.67 | (21.44) | (6.36) |
Quick Ratio |
— | 0.00 | 1.22 | 2.75 | 1.71 | 1.34 | 1.15 | 1.08 | 1.93 |
Current Ratio |
— | — | 1.27 | 3.08 | 1.98 | 1.56 | 1.29 | 1.18 | 2.02 |
Net Debt/EBITDA |
— | 0.11 | 553.60 | 12.05 | 125.89 | (3.58) | 22.38 | 5.79 | (2.34) |
Debt/Assets |
0.00% | 0.00% | 24.26% | 27.65% | 45.67% | 46.00% | 46.74% | 44.68% | 80.34% |
Debt/Equity |
— | 0.00 | 0.45 | 0.42 | 1.06 | 1.41 | 1.73 | 1.64 | (12.75) |
Asset Turnover |
— | 0.00 | 0.67 | 0.47 | 0.51 | 0.34 | 0.47 | 0.53 | 0.29 |
Operating CF/Net income |
— | 0.19 | 0.00 | 6.07 | 1.58 | (0.41) | (1.63) | 3.28 | 0.47 |
Capex/Depreciation |
— | (1.00) | (0.24) | (0.14) | (0.04) | (0.12) | (0.13) | (0.12) | (0.09) |
Interest Coverage |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| — | 44.63% | (12.20%) | (1.66%) | (16.53%) | (20.86%) | (14.10%) | (1.62%) | (152.11%) | |
| — | 0.00% | (5.13%) | (1.01%) | (9.07%) | (8.03%) | (4.23%) | (0.44%) | (21.09%) | |
ROIC |
— | 449.42% | (1.66%) | (2.19%) | (17.45%) | (15.45%) | (5.03%) | (0.43%) | (36.96%) |
Return on Tangible Assets |
— | 234.31% | (110.87%) | (6.67%) | (80.17%) | (85.82%) | (50.14%) | (7.19%) | (174.69%) |
Average Days of Receivables |
— | 0.00 | 84.93 | 85.59 | 98.24 | 196.75 | 167.16 | 148.42 | 241.81 |
Research and Development Expense of Revenue |
— | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
— | 44.94% | 46.15% | 64.92% | 73.65% | 92.61% | 69.06% | 67.62% | 86.56% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.73 | 0.51 | 0.29 | 0.30 | 0.26 | 0.20 | 0.00 |
Share Based Compensation of Revenue |
— | 0.00% | 16.22% | 24.65% | 2.57% | 4.30% | 2.66% | 1.41% | 2.53% |
Graham Net Nets |
— | 0.08 | 0.08 | (0.28) | (1.86) | (8.21) | (5.08) | (5.11) | (27.45) |
Graham Number |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 44.67 |
Earnings Yield |
— | 0.05% | 0.05% | (3.33%) | (44.04%) | (172.70%) | (55.16%) | (5.53%) | (858.14%) |
Free Cash Flow Yield |
— | (1.31%) | (1.31%) | (11.19%) | (79.36%) | 55.40% | 78.44% | (26.44%) | (467.97%) |
Revenue per Share |
— | 37.70 | 0.00 | 156.33 | 150.36 | 74.80 | 79.06 | 80.05 | 27.96 |
Operating CF per Share |
— | 0.91 | 0.00 | (20.35) | (42.32) | 7.21 | 11.75 | (2.16) | (9.42) |
Capex per Share |
— | (1.03) | 0.00 | (2.59) | (2.80) | (1.60) | (1.48) | (1.38) | (0.64) |
Free Cash Flow per Share |
— | (0.12) | 0.00 | (22.94) | (45.12) | 5.61 | 10.27 | (3.54) | (10.06) |
Cash per Share |
— | 0.17 | 0.00 | 25.70 | 11.94 | 1.95 | 9.77 | 4.10 | 2.54 |
Shareholders Equity per Share |
— | 0.00 | 0.00 | 249.31 | 126.31 | 64.23 | 43.66 | 40.63 | (4.81) |
Interest Debt per Share |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
— | 0.00 | 0.00 | 249.31 | 126.31 | 64.23 | 43.66 | 40.63 | (4.81) |
Free Cash Flow |
— | (0.73) | (8.02) | (128.74) | (318.81) | 47.39 | 95.41 | (35.34) | (130.19) |
Working Capital |
— | — | 30.70 | 264.45 | 211.93 | 149.10 | 106.43 | 62.36 | 144.29 |
Capital Expenditures |
— | (6.17) | (8.02) | (14.52) | (19.80) | (13.51) | (13.73) | (13.73) | (8.25) |
Net Current Asset Value |
— | 0.00 | (598.38) | (317.82) | (747.37) | (702.33) | (617.48) | (682.57) | (763.80) |
EV/EBIT |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
— | 0.03 | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
Net Profit Margin |
— | 12.43% | (7.61%) | (2.14%) | (17.82%) | (23.69%) | (9.10%) | (0.82%) | (72.14%) |
Price to Operating Income |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | |||||||||
Depreciation/Fixed assets |
— | 0.51 | 5.28 | 5.82 | 20.45 | 4.35 | 4.06 | 3.92 | 17.04 |
Cash ROIC |
— | (109.28%) | (0.50%) | (6.19%) | (16.82%) | 2.69% | 6.87% | (4.58%) | (16.64%) |
Accounts Receivable Turnover |
— | 0.00 | 3.26 | 5.30 | 4.32 | 2.02 | 2.17 | 2.42 | 1.28 |
Accounts Payable Turnover |
— | 3.34 | 7.13 | 17.85 | 9.85 | 6.83 | 9.68 | 8.09 | 8.94 |
Inventory Turnover |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
— | 155.96 | 29.24 | 16.00 | 60.76 | 29.46 | 40.65 | 40.78 | 26.29 |
Days of Inventory on Hand |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
— | — | 165.64 | 165.64 | 245.84 | 313.22 | 338.48 | 330.66 | 282.28 |
Average Payables |
— | 23.79 | 23.79 | 11.16 | 24.29 | 27.50 | 16.43 | 16.15 | 10.76 |
Average Assets |
— | 0.00 | 801.15 | 1,855.55 | 2,088.82 | 1,864.07 | 1,579.43 | 1,494.00 | 1,237.90 |
Average Common Equity |
— | 63.00 | 336.57 | 1,129.65 | 1,145.82 | 717.44 | 474.03 | 405.55 | 171.62 |
Columns are period end dates